Select committee: Business, Innovation, Science and Trade Committee
Conclusion 7
12th Report - UK-India Comprehensive Economic and Trade Agreement (CETA)
Published 21 Jan 2026
Addressed to Department for Business and Trade
Business, Innovation, Science and Trade Committee UK trade with the US, India and EU All items in this report Report on parliament.uk ↗ Inquiry on parliament.uk ↗
Conclusion (the committee's words)
The Committee concludes that the Agreement does not introduce significant changes to India’s intellectual property regime that are likely to support growth in UK pharmaceutical exports. At the same time, the Committee recognises India’s role as a major producer of generic medicines and the importance of retaining some flexibility within its IP framework. The Committee welcomes the establishment of the Working Group on Intellectual Property established under the Agreement. (Conclusion, Paragraph 64)
From: Business, Innovation, Science and Trade Committee, 12th Report - UK-India Comprehensive Economic and Trade Agreement (CETA) (HC 996), 21 January 2026
Government response
The government responded to the whole report on 17 April 2026 (deadline 21 March 2026).
Summary written by Accountability Index from the government's response. It is not the government's own words.The government responds to each recommendation mainly by describing existing structures and its approach to implementation, with a few stated commitments to update Parliament, publish data and monitor the agreement.
- On utilisation data, it will "endeavour to publish provisional data" within the first year after entry into force, "subject to information provision from Indian customs", and will update Parliament regularly.
- On mutual recognition of professional qualifications, it says this is "ultimately the decision of the regulators", but it "will seek to actively facilitate" such arrangements where they are of mutual interest.
- On the Responsible Business Conduct review, it will "update Parliament when the review is complete"; on labour market impacts, it says DBT "intends to monitor and evaluate the agreement".
- On debates, it "reaffirms" its commitment to provide a debate on any new trade deal during the statutory scrutiny period "where Parliamentary time allows".